The clinical management of bladder cancer has not changed significantly in several
decades. In particular, intravesical bacillus Calmette–Guérin (BCG) immunotherapy has …

Seventy percent of newly diagnosed bladder cancers are classified as non‐muscle‐invasive
bladder cancer (NMIBC) and are often associated with high rates of recurrence that require …

Harnessing RNA interference (RNAi) to silence aberrant gene expression is an emerging
approach in cancer therapy. Selective inhibition of an overexpressed gene via RNAi …

Patients with high‐grade Ta, T1, or carcinoma in situ non–muscle‐invasive bladder cancer
(NMIBC) are at high risk for recurrence and, more importantly, progression. Thus, both the …

The objective of this study was to evaluate the tolerability, to establish a dosing regimen, and
to evaluate the efficacy of intravesical docetaxel (DTX) formulations in a mouse model of …

Spindle and kinetochore-associated protein 1 (SKA1), a component of microtubule-binding
complex of kinetochore, is essential for proper chromosome segregation. Recently, SKA1 …

Transitional cell carcinoma (TCC) is the second most common urologic malignancy, and
70% of patients present with superficial or nonmuscle invasive bladder cancer (NMIBC) …

Em xin trân trọng cảm ơn thầy hướng dẫn, PGS. TS. Đỗ Trường Thành-Trưởng khoa Phẫu
thuật Tiết niệu Bệnh viện Hữu Nghị Việt Đức đã trực tiếp hướng dẫn em trong suốt thời gian …

Mesoporous magnetic colloidal nanocrystal clusters (MCNCs) are featured with high
magnetization, adequate surface area, excellent colloidal stability, good biocompatibility …

Background: This study will aim to appraise the efficacy and safety of pirarubicin for the
treatment of patients with nonmuscle invasive bladder cancer (NMIBC). Methods: We will …